These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen. Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522 [TBL] [Abstract][Full Text] [Related]
9. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase. Stewart-Tull DE; Lucas C; Bleakley CR Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770 [TBL] [Abstract][Full Text] [Related]
10. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals]. Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720 [TBL] [Abstract][Full Text] [Related]
11. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization. Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR. Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636 [TBL] [Abstract][Full Text] [Related]
14. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera. Pierce NF; Cray WC; Sircar BK Infect Immun; 1978 Jul; 21(1):185-93. PubMed ID: 711314 [TBL] [Abstract][Full Text] [Related]
15. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Svennerholm AM; Holmgren J Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131 [TBL] [Abstract][Full Text] [Related]
16. Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid. Pierce NF Ciba Found Symp; 1976; (42):129-47. PubMed ID: 1086763 [TBL] [Abstract][Full Text] [Related]
17. Immune response of the intestinal mucosa to cholera toxoid. Pierce NF; Sack RB J Infect Dis; 1977 Aug; 136 Suppl():S113-7. PubMed ID: 894085 [TBL] [Abstract][Full Text] [Related]
18. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid. Sinha VB; Bhaskaran K Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387 [TBL] [Abstract][Full Text] [Related]
19. A toxoid prepared from cholera toxin by iodination. Heneine IF; Lahmann WM; Rocha OA Braz J Med Biol Res; 1992; 25(9):913-7. PubMed ID: 1342838 [TBL] [Abstract][Full Text] [Related]
20. [Effect of revaccination in persons inoculated primarily with whole-cell and toxoid cholera vaccines]. Kiseleva IE; Domaradskiĭ IV; Erokhin EP; Kirdeev VK; Kiseleva VI Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):64-7. PubMed ID: 4409388 [No Abstract] [Full Text] [Related] [Next] [New Search]